TY - JOUR
T1 - Role of endothelin ETB receptors in the renal hemodynamic and excretory responses to big endothelin-1
AU - Konishi, Fumiko
AU - Okada, Yuka
AU - Takaoka, Masanori
AU - Gariepy, Cheryl E.
AU - Yanagisawa, Masashi
AU - Matsumura, Yasuo
N1 - Funding Information:
This study was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture of Japan. Dr. Yanagisawa is an investigator of the Howard Hughes Medical Institute. The authors are grateful to Dr. Terry J. Opgenorth (Abbott Laboratories) for supporting this work.
PY - 2002/9/13
Y1 - 2002/9/13
N2 - We determined the role of endothelin ETB receptor in the renal hemodynamic and excretory responses to big endothelin-1, using A-192621, a selective endothelin ETB receptor antagonist and the spotting-lethal (sl) rat, which carries a naturally occurring deletion in the endothelin ETB receptor gene. An intravenous injection of big endothelin-1 produced a hypertensive effect, which is greater in wild-type (+/+) rats pretreated with A-192621 and in homozygous (sl/sl) rats. Big endothelin-1 markedly increased urine flow, urinary excretion of sodium and fractional excretion of sodium in wild-type rats treated with the vehicle. These excretory responses to big endothelin-1 were markedly reduced by pharmacological endothelin ETB receptor blockade. On the other hand, big endothelin-1 injection to the endothelin ETB receptor-deficient homozygous animals resulted in a small diuretic effect. When renal perfusion pressure was protected from big endothelin-1-induced hypertension by an aortic clamp, the excretory responses in vehicle-treated wild-type rats were markedly attenuated. In homozygous or A-192621-treated wild-type rats, there was a small but significant decreasing effect in urine flow. In addition, big endothelin-1 significantly elevated nitric oxide (NO) metabolite production in the kidney of wild-type rats but not in the homozygous rats. We suggest that the diuretic and natriuretic responses to big endothelin-1 consist of pressure-dependent and pressure-independent effects and that the increased NO production via the activation of endothelin ETB receptors in the kidney is closely related to the big endothelin-1-induced excretory responses.
AB - We determined the role of endothelin ETB receptor in the renal hemodynamic and excretory responses to big endothelin-1, using A-192621, a selective endothelin ETB receptor antagonist and the spotting-lethal (sl) rat, which carries a naturally occurring deletion in the endothelin ETB receptor gene. An intravenous injection of big endothelin-1 produced a hypertensive effect, which is greater in wild-type (+/+) rats pretreated with A-192621 and in homozygous (sl/sl) rats. Big endothelin-1 markedly increased urine flow, urinary excretion of sodium and fractional excretion of sodium in wild-type rats treated with the vehicle. These excretory responses to big endothelin-1 were markedly reduced by pharmacological endothelin ETB receptor blockade. On the other hand, big endothelin-1 injection to the endothelin ETB receptor-deficient homozygous animals resulted in a small diuretic effect. When renal perfusion pressure was protected from big endothelin-1-induced hypertension by an aortic clamp, the excretory responses in vehicle-treated wild-type rats were markedly attenuated. In homozygous or A-192621-treated wild-type rats, there was a small but significant decreasing effect in urine flow. In addition, big endothelin-1 significantly elevated nitric oxide (NO) metabolite production in the kidney of wild-type rats but not in the homozygous rats. We suggest that the diuretic and natriuretic responses to big endothelin-1 consist of pressure-dependent and pressure-independent effects and that the increased NO production via the activation of endothelin ETB receptors in the kidney is closely related to the big endothelin-1-induced excretory responses.
KW - Diuresis
KW - Endothelin ET receptor
KW - Endothelin-1, big
KW - Hypertension
KW - Nitric oxide (NO)
UR - http://www.scopus.com/inward/record.url?scp=0037072550&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0037072550&partnerID=8YFLogxK
U2 - 10.1016/S0014-2999(02)02228-8
DO - 10.1016/S0014-2999(02)02228-8
M3 - Article
C2 - 12231389
AN - SCOPUS:0037072550
SN - 0014-2999
VL - 451
SP - 177
EP - 184
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
IS - 2
ER -